PIIND2021-04-012021-06-30in-bse-fin:OneOperatingExpenses01Member PIIND2021-04-012021-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member PIIND2021-04-012021-06-30in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member PIIND2021-04-012021-06-30in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss02Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares PIIND 2021-04-01 2022-03-31 2021-07-22 INR Millions First quarter Single segment Agri 2021-04-01 2021-06-30 Unaudited Consolidated 11938000000.00 277000000.00 12215000000.00 7987000000.00 651000000.00 -1924000000.00 1190000000.00 34000000.00 487000000.00 1545000000.00 9970000000.00 2245000000.00 0.00 2245000000.00 407000000.00 -2000000.00 405000000.00 0.00 1840000000.00 0.00 0.00 0.00 32000000.00 1872000000.00 -44000000.00 1828000000.00 1828000000.00 0.00 1828000000.00 0.00 152000000.00 1 12.34 12.34 0.00 0.00 12.34 12.34 1. The above Consolidated financial results were reviewed and recommended by the Audit Committee of the Board and approved by the Board of Directors at their meeting held on July 30, 2021. 2. Consolidated Financial results for all the periods presented have been prepared in accordance with the recognition and measurement principles of lnd AS notified under the Companies (Indian Accounting Standards) Rules, 2015 as amended from time to time. 3. The Consolidated financial results include the results of the following entities namely, a) PI Industries Limited (Parent); Subsidiaries b) PILL Finance and Investment Limited c) PI Life Science Research Limited d) PI Japan Co. Limited e) lsagro (Asia) Agrochemicals Private Limited f) Jivagro Limited g) PI ENZACHEM Private Limited. h) PI FERMACHEM Private Limited ; Controlled Trust. i) PII ESOP Trust; Equity accounted entities: ]) PI Kumiai Private Limited (Joint Venture) k) Solinnos Agro Sciences Private Limited (Associate). 4. The Figures for the quarter ended March 31, 2021 are the balancing figures between audited figures in respect of full financial year ended March 31, 2021 and the published unaudited year to date figures for the nine months period ended December 31, 2020. 5. The Company is in the business of manufacturing and distribution of Agro Chemicals and accordingly has one reportable business segment viz. 'Agro Chemicals'. 6. In management's evaluation, there is no significant impact of the COVID-19 pandemic on current and future business condition of the Company, liquidity position and cash flow and therefore, no material adjustments are required in the financial results. Management will continue to closely monitor the situation. 7. The Company has raised Rs.20 ,000 million during the previous year through Qualified Institutional Placement (QIP) of equity shares. The Company has issued 13,605,442 equity shares of face value of~ 1 each at a price of Rs.1,470 per Equity Share, including a premium of Rs.1,469 per Equity Share. Funds received pursuant to QIP ( net of expense~ 250 million) remain invested in fixed deposits. liquid and other debt mutual funds. 8. The previous period's figures have been regrouped/ rearranged/ reclassified wherever necessary. Other 1545000000.00